152 related articles for article (PubMed ID: 7883445)
21. Attempts to induce resistance in mice to Schistosoma japonicum and Schistosoma mansoni by exposure to crude schistosome antigens plus cloned glutathione-S-transferases.
Mitchell GF; Davern KM; Wood SM; Wright MD; Argyropoulos VP; McLeod KS; Tiu WU; Garcia EG
Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():377-85. PubMed ID: 2129038
[TBL] [Abstract][Full Text] [Related]
22. The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni.
Mountford AP; Fisher A; Wilson RA
Parasite Immunol; 1994 Oct; 16(10):521-7. PubMed ID: 7870462
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the protective resistance induced by 60Co-irradiated cercariae and schistosomula of the WFFS and NMRI strains of Schistosoma mansoni.
James ER; Dobinson AR
J Helminthol; 1985 Dec; 59(4):313-7. PubMed ID: 3937852
[TBL] [Abstract][Full Text] [Related]
24. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
Gregoire RJ; Shi MH; Rekosh DM; Loverde PT
J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines.
Ganley-Leal LM; Guarner J; Todd CW; Da'Dara AA; Freeman GL; Boyer AE; Harn DA; Secor WE
Parasite Immunol; 2005 Sep; 27(9):341-9. PubMed ID: 16149992
[TBL] [Abstract][Full Text] [Related]
26. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance.
James SL; Cheever AW; Caspar P; Wynn TA
Infect Immun; 1998 Aug; 66(8):3510-8. PubMed ID: 9673227
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of protective immunity in mice induced by drug-attenuated larvae of Schistosoma mansoni. Antigen localization and antibody responses.
Mountford AP; Coulson PS; Saunders N; Wilson RA
J Immunol; 1989 Aug; 143(3):989-95. PubMed ID: 2501388
[TBL] [Abstract][Full Text] [Related]
28. Homologous and heterologous protective immunity to Egyptian strains of Schistosoma mansoni and S. haematobium induced by ultraviolet-irradiated cercariae.
Dean DA; Mangold BL; Harrison RA; Ricciardone MD
Parasite Immunol; 1996 Aug; 18(8):403-10. PubMed ID: 9229394
[TBL] [Abstract][Full Text] [Related]
29. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes.
Smithers SR; Hackett F; Ali PO; Simpson AJ
Parasite Immunol; 1989 Jul; 11(4):301-18. PubMed ID: 2476710
[TBL] [Abstract][Full Text] [Related]
30. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
Pemberton RM; Wilson RA
Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008
[TBL] [Abstract][Full Text] [Related]
31. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary leukocytic responses are linked to the acquired immunity of mice vaccinated with irradiated cercariae of Schistosoma mansoni.
Aitken R; Coulson PS; Wilson RA
J Immunol; 1988 May; 140(10):3573-9. PubMed ID: 3129495
[TBL] [Abstract][Full Text] [Related]
33. Effect of mouse strain on humoral responses to Schistosoma mansoni irradiated cercariae vaccine.
El Amir A
Egypt J Immunol; 2008; 15(1):51-63. PubMed ID: 20306669
[TBL] [Abstract][Full Text] [Related]
34. Schistosoma mansoni: characterization of two protective monoclonal antibodies.
Bickle QD; Andrews BJ; Taylor MG
Parasite Immunol; 1986 Jan; 8(1):95-107. PubMed ID: 3083390
[TBL] [Abstract][Full Text] [Related]
35. Immunization of mice with ultraviolet-attenuated cercariae of Schistosoma mansoni transiently reduces the fecundity of challenge worms.
el Ridi R; Ozaki T; Sato H; Inaba T; Kamiya H
Int J Parasitol; 1997 May; 27(5):581-6. PubMed ID: 9193952
[TBL] [Abstract][Full Text] [Related]
36. Immunological cross reactivity between Schistosoma mansoni and cholera toxin.
Akhiani AA; Nilsson LA; Ouchterlony O
Parasite Immunol; 1997 Aug; 19(8):355-61. PubMed ID: 9292894
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and functional properties of Th lines and clones recognizing larval antigens of Schistosoma mansoni.
Pemberton RM; Coulson PS; Smythies LE; Wilson RA
Parasite Immunol; 1993 Jul; 15(7):373-82. PubMed ID: 8105441
[TBL] [Abstract][Full Text] [Related]
38. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm.
Hirsch C; Zouain CS; Alves JB; Goes AM
Parasitology; 1997 Jul; 115 ( Pt 1)():21-8. PubMed ID: 9280892
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Schistosoma mansoni 44.7/56.8 kDa egg antigens recognized by human monoclonal antibodies which induce protection against experimental infection and proliferation of peripheral blood mononuclear cells from schistosomiasis patients.
Hirsch C; Almeida CA; Doughty BL; Goes AM
Vaccine; 1997 Jun; 15(9):948-54. PubMed ID: 9261940
[TBL] [Abstract][Full Text] [Related]
40. Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.
Hassan AS; Zelt NH; Perera DJ; Ndao M; Ward BJ
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007490. PubMed ID: 31790394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
